Reduction of HDAC2 expression in human induced pluripotent stem cell derived neurons improves neuronal maturation, mitochondrial dynamics and cellular neurodegenerative disease phenotypes.
Harald Frankowski, Fred Yeboah, Bonnie J. Berry, Chizuru Kinoshita, Michelle LeeiD, Kira M. EvittsiD, Joshua DavisiD, Yoshito Kinoshita, Richard S. MorrisoniD, Jessica E. YoungiD
Abstract
Histone deacetylase 2 (HDAC2) is a major HDAC protein in the adult brain and has been shown to regulate many neuronal genes. Aberrant expression of HDAC2 and subsequent dysregulation of neuronal gene expression is implicated in neurodegeneration and brain aging. Human induced pluripotent stem cell-derived neurons (hiPSC-Ns) are widely used models for studying neurodegenerative disease mechanisms, but the role of HDAC2 in hiPSC-N differentiation and maturation has not been explored. In this study, we show that levels of HDAC2 progressively decrease as hiPSCs are differentiated towards neurons. This suppression of HDAC2 inversely corresponds to an increase in neuron-specific isoforms of Endophilin-B1, a multifunctional protein involved in mitochondrial dynamics. Expression of neuron-specific isoforms of Endophilin-B1 is accompanied by concomitant expression of a neuron-specific alternative splicing factor, SRRM4. Manipulation of HDAC2 and Endophilin-B1 using lentiviral approaches shows that knock-down of HDAC2 or overexpression of a neuron-specific Endophilin-B1 isoform promotes mitochondrial elongation and protects against cytotoxic stress in hiPSC-Ns, while HDAC2 knock-down specifically influences genes regulating mitochondrial dynamics and synaptogenesis. Furthermore, HDAC2 knock-down promotes enhanced mitochondrial respiration and reduces levels of neurotoxic amyloid beta peptides. Collectively, our study demonstrates a role for HDAC2 in hiPSC-neuronal differentiation, highlights neuron-specific isoforms of Endophilin-B1 as a marker of differentiating hiPSC-Ns, and demonstrates that HDAC2 regulates key neuronal and mitochondrial pathways in hiPSC-Ns.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 26
- FWCI
- 1.10
- Field percentile
- top 25%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Histone deacetylase inhibition expands cellular proteostasis repertoires to enhance neuronal stress resilience
Caitlin Ann Taylor, Maya Maor-Nof, … Kang Shen·bioRxiv·Aug 21, 2024
- Extracellular Vesicles from hiPSC-derived NSCs Protect Human Neurons against Abeta-42 Oligomers Induced Neurodegeneration, Mitochondrial Dysfunction and Tau Phosphorylation
Shama Rao, Leelavathi Narayana Madhu, … Ashok Kumar Shetty·Stem Cell Research & TherapyPeer-reviewed·Apr 18, 2025
- CHCHD10 OR CHCHD2 ARE NOT REQUIRED FOR HUMAN MOTOR NEURON DIFFERENTIATION IN VITRO BUT MODIFY SYNAPTIC TRANSCRIPTOMES
Sandra Harjuhaahto, Tiina S. Rasila, … Henna Tyynismaa·Neurobiology of DiseasePeer-reviewed·May 10, 2020
- Insights for disease modeling from single cell transcriptomics of iPSC-derived Ngn2-induced neurons and astrocytes across differentiation time and co-culture
D Das, Shreyash Sonthalia, … Dimitrios Avramopoulos·BMC BiologyPeer-reviewed·Apr 2, 2024
- Highly enriched hiPSC-derived midbrain dopaminergic neurons robustly models Parkinson's disease.
Gurvir S. Virdi, Minee L. Choi, … Sonia Gandhi·bioRxiv·Sep 8, 2020
- Role of human induced pluripotent stem cell-derived spinal cord astrocytes in the functional maturation of motor neurons in a multielectrode array system
Arens Taga, Raha Maryam Dastgheyb, … Nicholas John Maragakis·Stem Cells Translational MedicinePeer-reviewed·Oct 21, 2019